Early Morning Technical Highlights on Biotech Stocks

LONDON, UK / ACCESSWIRE / May 31, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include BioCryst Pharma, Agenus, Cempra, and Hemispherx Biopharma.

Today, ActiveWallSt.com is promoting its technical alert briefings. Get all of our alerts free by signing up to http://www.activewallst.com/register/.

The Biotech segment continues to have a rough year, but a number of stocks in this space have managed to post positive returns. Let us see how this ongoing volatile environment within the biotech space is affecting some of the big players in the industry. Register for the free alerts on these stocks by clicking below:

http://www.activewallst.com/register/

Today, ActiveWallSt.com takes a brief technical look at how each of the companies mentioned above have performed over the last few trading sessions.

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX)

Shares in biotechnology Company, BioCryst Pharmaceuticals Inc., rose 0.60%, finishing last Friday’s trading session at $3.38 with a total volume of 834,907 shares traded. The stock has gained 1.81% in the last month and 69.85% over the previous three months. The Company’s shares are trading above their 50-day moving average by 12.19%. Additionally, BioCryst Pharmaceuticals’ stock has a Relative Strength Index (RSI) of 60.78.

Agenus Inc. (NASDAQ: AGEN)

Massachusetts-based Agenus Inc. operates as an immuno-oncology Company. The Company’s stock ended the session at $4.05, gaining 3.85%. A total volume of 1.02 million shares was traded. The Company’s shares have advanced 5.47% in the past month and 46.21% over the previous three months. The stock is trading 3.66% above its 50-day moving average. Moreover, shares of Agenus have an RSI of 61.75.

Cempra Inc. (NASDAQ: CEMP)

On Friday, shares in North Carolina headquartered clinical-stage pharmaceutical Company, Cempra Inc., recorded a trading volume of 973,621 shares, which was higher than their three months average volume of 686,120 shares. The stock climbed 2.07%, closing the day at $18.26. The Company’s shares have gained 5.00% in the last one month and 8.50% in the previous three months. The stock is trading 7.78% above its 50-day moving average. Additionally, shares of Cempra have an RSI of 63.36.

Hemispherx Biopharma Inc. (AMEX: HEB)

Shares in Pennsylvania-based specialty pharmaceutical Company, Hemispherx Biopharma Inc., recorded a trading volume of 297,213 shares and ended the session 1.83% higher at $0.12. The stock has gained 52.75% on an YTD basis. The Company’s shares are trading below their 50-day moving average by 5.56%. Furthermore, Hemispherx Biopharma stock has an RSI of 49.55. Trade alert on HEB is available for free at:

http://www.activewallst.com/register/

—

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 440561